Skip to content

Myrna Mousa, MD

NPI 1598458713ActiveIndividual· Internal Medicine, Pulmonary Disease· Loma Linda, CA

Internal Medicine, Pulmonary Disease (MD) in Loma Linda, California, licensed in CA, with an NPI issued in June 2023. Part D covered 74 prescriptions written in 2024, 88% of them generic. Ani Pharmaceuticals, Inc. reported $116.99 in payments in 2025, mostly food and beverage.

Overview

NPI1598458713
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedJun 1, 2023
Last updated in NPPESJun 26, 2026
Certified by providerJun 26, 2026

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Pulmonary Disease Primary207RP1001X11644CA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)74 · 129 30-day fills
Patients27
Total drug cost$11,546
Generic share88% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$116.99 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Ani Pharmaceuticals, Inc.$116.991

What the 2025 payments were for

  • Food and Beverage$116.99 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Pulmonary Disease providers in Loma Linda

All Internal Medicine, Pulmonary Disease providers in California →